Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms

US9403815B2 · kind B2 · utility

Assignees

• The Regents of the University of California · US
• The General Hospital Corporation · US

Inventors

• Steven L. Wagner · Del Mar, US
• Soan Cheng · San Diego, US
• William C. Mobley · Palo Alto, US
• Rudolph E. Tanzi · Canton, US

Key dates

• Filing date: Jun 24, 2011
• Grant date: Aug 2, 2016
• Expiry date: Jul 8, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07F9/65583
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention provides a novel compound having a structure corresponding to Formula (I):(A)-(B)-(C)-(D)  (I)or a pharmaceutically acceptable salt or prodrug thereof and methods for using them.